Last updated: April 15, 2024
Sponsor: Scripps Translational Science Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Defect
Neurologic Disorders
Fibromyalgia
Treatment
Wearable device
Clinical Study ID
NCT05741112
LCWS 001
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Is at least 18 years old.
- Has a self/and or physician diagnosis of:
- Long COVID (based on the WHO working definition),
- ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based onIOM criteria), and/or
- POTS (Postural Orthostatic Tachycardia Syndrome).
- Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
- Owns a wearable device they are willing to use for this study or does not own a deviceand agrees to utilize a study-provided one.
- Agrees to wear the device throughout the study period, share the data with the study,and sync data at least weekly.
- Has access to a smartphone or tablet to enable syncing wearable data and viewingdevice feedback.
- Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventionssuch as medical treatment, self-management, and other interventional studies.
- Agrees to complete at least 75% of the study surveys.
Exclusion
Exclusion Criteria:
- As long as they meet inclusion there is no exclusion
Study Design
Total Participants: 100500
Treatment Group(s): 1
Primary Treatment: Wearable device
Phase:
Study Start date:
November 16, 2023
Estimated Completion Date:
December 01, 2025
Study Description
Connect with a study center
Scripps Research
La Jolla, California 92037
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.